BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 6945022)

  • 1. The use of glycogen studies in the evaluation of treatment for carcinoma of the cervix uteri.
    Das DK; Chowdury JR
    Acta Cytol; 1981; 25(5):566-71. PubMed ID: 6945022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of the occurrence and distribution of glycogen in cervical cells exfoliated under different physiologic and pathologic conditions.
    Chowdhury TR; Chowdhury JR
    Acta Cytol; 1981; 25(5):557-65. PubMed ID: 6945021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytochemical determination of the protein sulfhydryl groups in the normal squamous epithelium, in erosion and in squamous cell carcinoma of the uterine cervix].
    Tolmachev VS
    Vopr Onkol; 1974; 20(8):17-21. PubMed ID: 4428640
    [No Abstract]   [Full Text] [Related]  

  • 4. Late recurrent squamous cell carcinoma of the cervix uteri or vagina after successful initial treatment.
    Villasanta U; Prempree T; Kwon T
    Md State Med J; 1983 Feb; 32(2):111-4. PubMed ID: 6843186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
    Ma SK; Wu LY; Sun YC; Li B; Zhang HT
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic value of estrogen and progesterone receptors in epidermoid carcinoma of the cervix uteri].
    Gougeon E; Peyrat JP; Rohart J; Castelain B; Demaille A
    Rev Fr Gynecol Obstet; 1988 Jun; 83(6):411-3. PubMed ID: 3406634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervicovaginal cytology in the diagnosis of recurrent carcinoma of the cervix uteri.
    Rayburn WF; van Nagell JR
    Surg Gynecol Obstet; 1980 Jul; 151(1):15-6. PubMed ID: 7384980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pelvic recurrence of cervical cancer: the prognostic relationship to the retreatment modalities].
    Zhang X; Zhang X; Liu A
    Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):611-3. PubMed ID: 8745509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal vaginal cytohormonal pattern in 597 healthy women and 301 patients with genital cancer.
    Efstratiades M; Tamvakopoulou E; Papatheodorou B; Batrinos M
    Acta Cytol; 1982; 26(2):126-30. PubMed ID: 6952711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytological method in evaluation of the effectiveness of radioisotope teletherapy of cervical cancer in different oxygen regimens].
    Nikitina NI; Nevskaia EA; Volkova MA; Falileeva EP; Dar'ialova SL
    Vopr Onkol; 1978; 24(11):35-42. PubMed ID: 741698
    [No Abstract]   [Full Text] [Related]  

  • 11. Cervical cancer diagnosed after simple hysterectomy for persistent abnormal cervical smears: a clinical dilemma.
    Pisal N; Sindos M; Freeman-Wang T; Ramchandra S; Michala S; Singer A
    J Obstet Gynaecol; 2004 Feb; 24(2):186-7. PubMed ID: 14766469
    [No Abstract]   [Full Text] [Related]  

  • 12. [A study on estrogen and progesterone receptors in the human cervix and cervical squamous carcinoma].
    Yang ZR; Cao ZY
    Zhonghua Fu Chan Ke Za Zhi; 1988 Sep; 23(5):283-6, 317-8. PubMed ID: 3250810
    [No Abstract]   [Full Text] [Related]  

  • 13. A 5-year review of FIGO stage IB cervical cancer in an Asian population.
    Tay EH; Yeap ML; Ho TH
    Singapore Med J; 1997 Dec; 38(12):520-4. PubMed ID: 9550918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of the cervix or vagina, 10 or more years after therapy: recurrence or new primary?
    Geisler HE
    J Indiana State Med Assoc; 1974 Aug; 67(8):711-2. PubMed ID: 4858779
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytopathology and the management of early invasive cancer of the uterine cervix.
    Johnston WW; Myers B; Creasman WT; Owens SM
    Obstet Gynecol; 1982 Sep; 60(3):350-3. PubMed ID: 7121916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer of the uterine cervix.
    Cannistra SA; Niloff JM
    N Engl J Med; 1996 Apr; 334(16):1030-8. PubMed ID: 8598842
    [No Abstract]   [Full Text] [Related]  

  • 17. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
    Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
    Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation and treatment of cervical cancer].
    Morice P; Haie-Meder C; Lhommé C
    Rev Prat; 2001 Sep; 51(13):1432-8. PubMed ID: 11601072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre MR
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):215-23. PubMed ID: 17125903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer complicated by pregnancy: episiotomy site recurrences following vaginal delivery.
    Cliby WA; Dodson MK; Podratz KC
    Obstet Gynecol; 1994 Aug; 84(2):179-82. PubMed ID: 8041526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.